Share This

Related Topics News -

     
 Title only   |   Print    Next page > 
     
復旦張江藥品里葆多調整零售價 降幅不低於35%

2025-05-01T  
《業績》復旦張江(01349.HK)首季純利266.51萬人幣升13.5%

2025-04-28T  
復旦張江斥2億人民幣認購結構性存款產品

2025-04-02T  
復旦張江研發用於膀胱癌患者藥品完成首例受試者入組

2025-03-13T  
《業績》復旦張江全年淨利潤3,973萬人民幣 倒退63.4%

2025-02-27T  
《盈警》復旦張江研發費用增加 料全年少賺52%-68%

2025-01-19T  
復旦張江斥2億人民幣認購中行結構性存款產品

2025-01-08T  
復旦張江認購平安銀行2億元人幣理財產品

2025-01-03T  
復旦張江認購浦發銀行2億人幣結構性存款產品

2025-01-02T  
復旦張江(01349.HK)奧貝膽酸片治療膽管炎獲受理藥物上市申請

2024-10-31T  
  Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.